Venclyxto gains approval in Europe
In a trial, the drug in combo with Gazyvaro led to a 65% reduction in the risk of disease worsening or death.
Read More
Author: Anna Smith
“Two-pronged” DNA repair attack could kill drug-resistant cancers
The new study “establishes the basis for a potentially exciting new approach to treatment.”
Read More
Ajovy bags NICE approval
The anti-CGRP preventive therapy is the first of-its-kind to be recommended by NICE.
Read More
FDA green lights Opdivo, Yervoy combo for hepatocellular carcinoma
The combo has been granted Accelerated Approval in the US.
Read More
Setback for MedDay’s MD1003 as drug fails non-active progressive MS trial
MedDay will review the latest findings in detail “to understand these outcomes to help inform future clinical research in progressive MS and other neurological diseases.”
Read More- Transgene completes randomisation in phase 2 trial of tg4050
- Bayer wins MHRA approval for Kerendia in heart failure
- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
- Kainova expands DT 7012 trial into Europe
- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
